RYZ801 is an Ac-225–labeled GPC3-targeted radioligand that binds GPC3 on tumor cells and delivers short-range, high–linear energy transfer alpha particles. The emitted alpha radiation causes clustered DNA double-strand breaks in GPC3-positive cells, leading to irreparable damage and cell death while limiting off-target exposure due to the short path length.